Abstract
Radon concentration alone may not be an adequate surrogate to measure for lung cancer risk in all residential radon epidemiologic lung cancer studies. The dose delivered to the lungs per unit radon exposure can vary significantly with exposure conditions. These dose-effectiveness variations can be comparable to spatial and temporal factor variations in many situations. New technologies that use surface-deposited and implanted radon progeny activities make more accurate dose estimates available for future epidemiologic studies.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Air Pollutants, Radioactive / adverse effects*
-
Air Pollutants, Radioactive / analysis
-
Air Pollution, Indoor / adverse effects*
-
Air Pollution, Indoor / analysis
-
Biomarkers
-
Carcinogens, Environmental / adverse effects*
-
Carcinogens, Environmental / analysis
-
Dose-Response Relationship, Radiation
-
Environmental Exposure / adverse effects*
-
Environmental Exposure / analysis
-
Housing
-
Humans
-
Lung Neoplasms / etiology*
-
Neoplasms, Radiation-Induced / etiology*
-
Radon / adverse effects*
-
Radon / analysis
-
Risk Assessment
Substances
-
Air Pollutants, Radioactive
-
Biomarkers
-
Carcinogens, Environmental
-
Radon